Market Cap : 76.09 B | Enterprise Value : 89 B | PE Ratio : 46.00 | PB Ratio : 2.97 |
---|
NYSE:BDX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:BDX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Debt-to-EBITDA measures a company's ability to pay off its debt.
Becton, Dickinson and Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $1,682 Mil. Becton, Dickinson and Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $14,683 Mil. Becton, Dickinson and Co's annualized EBITDA for the quarter that ended in Jun. 2022 was $4,216 Mil. Becton, Dickinson and Co's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2022 was 3.88.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's
The historical rank and industry rank for Becton, Dickinson and Co's Debt-to-EBITDA or its related term are showing as below:
During the past 13 years, the highest Debt-to-EBITDA Ratio of Becton, Dickinson and Co was 7.30. The lowest was 1.79. And the median was 4.63.
The historical data trend for Becton, Dickinson and Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Becton, Dickinson and Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Becton, Dickinson and Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Becton, Dickinson and Co's Debt-to-EBITDA falls into.
Debt-to-EBITDA measures a company's ability to pay off its debt.
Becton, Dickinson and Co's Debt-to-EBITDA for the fiscal year that ended in Sep. 2021 is calculated as
Debt-to-EBITDA | = | Total Debt | / | EBITDA | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | EBITDA | |
= | (500 | + | 17110) | / | 4984 | |
= | 3.53 |
Becton, Dickinson and Co's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2022 is calculated as
Debt-to-EBITDA | = | Total Debt | / | EBITDA | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | EBITDA | |
= | (1682 | + | 14683) | / | 4216 | |
= | 3.88 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2022) EBITDA data.
In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's
Thank you for viewing the detailed overview of Becton, Dickinson and Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Hickey David | officer: EVP & President, Life Sciences | BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417 |
Neal Shana Carol | officer: Chief People Officer | 9120 LOCKWOOD BOULEVARD MECHANICSVILLE VA 23116 |
Ezell Antoine C | officer: EVP, President, NA & CMO | BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417 |
Spoerel Thomas J | officer: VP Controller & Chief Acct Off | BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417 |
Brown William M | director | HARRIS CORPORATION 1025 W NASA BOULEVARD MELBOURNE FL 32919 |
Larson Betty D | officer: EVP HR & CHRO | C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 |
Khichi Samrat S. | officer: EVP and General Counsel | C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 |
Conroy Alexandre | officer: EVP of Integrated Supply Chain | BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417 |
Campion Simon D | officer: EVP and Segment President | BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417 |
Scott Bertram L | director | C/O BECTON DICKERSON & CO 1 BECTON DR FRANKLIN LAKES NJ 07417 |
Jones Christopher Ian Montague | director | 110, BANBURY ROAD OXFORD X0 OX2 6JU |
Pomeroy Claire | director | BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417 |
Fraser Claire | director | C/O BECTON, DICKINSON AND COMPANY FRANKLIN LAKES NJ 07465 |
Melcher David F | director | 1650 TYSONS BOULEVARD SUITE 1700 MCLEAN VA 22102 |
Byington Carrie L | director | BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417 |
Other Sources
By Fool 2022-01-26
By Zacks 2022-01-27
By Zacks 2022-03-24
By Zacks 2022-02-03
By Zacks 2022-03-24
By Zacks 2022-01-28
By Zacks 2022-01-31
By tipranks.com 2022-02-09
By Zacks 2022-01-14
By Zacks 2022-02-02